Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Intel Strategy for Achieving Wealth and Off Topic -- Ignore unavailable to you. Want to Upgrade?

To: Sonny McWilliams who wrote (13880)	12/2/1997 11:42:00 PM
From: W. Clinton Terry	Read Replies (1) \| Respond to of 27012

Sonny: I was of course kidding. When I heard about COMS I though of you and was sympathetic, especially since WLA clobbered me yesterday. My fault actually as I put that one away in my IRA and did not think that I had to watch it diligently. I suppose even if I had, I would not have realized the import of the problem with the drug in terms of the stock performance, certainly not to the extent of a 27 point drop. The more I read up on this, the less sense it all made to me. Drug thearpy should always be under the supervision of a physician and if the dosage is not right or if there is reaction, then remedial actions are taken. The liver possibility was known ahead of time. I do not see WLA ditching the drug even if hundreds of cases pop up when more than 800,000 are taking the medicine. Even if 5 percent have problems with it and assuming the problems are correctable, then the other 95 percent are being assisted. Maybe I am not looking at this correctly. In any event, the techs may be in rut for awhile more thanks to Kurlack. The way Intel went down today, I would be fearful of what might transpire tomorrow. We'll see. So far the Globex looks ok and the foreign markets do not appear to be too extreme. Clinton